Some Stem Cell Experts Want Out of Documentary After Funding Source Revealed
By Erin Allday,
San Francisco Chronicle
| 06. 15. 2019
A new documentary about stem cell therapy is being questioned by some of those who appear in it — prominent cellular scientists who say they weren’t aware of who was backing the project when they agreed to participate.
The 10-part series is set to launch online Monday. The filmmakers said they may delay the premiere because some people interviewed for the project no longer want to be involved, after learning that the movie was funded in part by for-profit stem cell providers who are under federal investigation. Some scientists said they fear the documentary may promote what they consider junk science.
A five-minute trailer for “The Healthcare Revolution” is online at the website www.healthcarerev.org, where a surprisingly deep lineup of “expert sources” in stem cells is listed along with the institutions they represent.
Among the scientists named is Dr. Maria Millan, head of the California Institute for Regenerative Medicine, the state’s stem cell funding agency. Also named are three consumer stem cell providers who have been sued by the U.S. Food and Drug Administration to stop their operations; one...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...